Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Detection of cross-reactive IgA against SARS-CoV-2 spike 1 subunit in saliva

Keiichi Tsukinoki, Tatsuo Yamamoto, Keisuke Handa, Mariko Iwamiya, Juri Saruta, Satoshi Ino, Takashi Sakurai
doi: https://doi.org/10.1101/2021.03.29.21253174
Keiichi Tsukinoki
1Department of Environmental Pathology, Graduate School of Dentistry, Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tsukinoki@kdu.ac.jp
Tatsuo Yamamoto
2Department of Dental Sociology, Graduate School of Dentistry, Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keisuke Handa
3Department of Oral Biochemistry, Graduate School of Dentistry, Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariko Iwamiya
4Department of Clinical Laboratory, Yokosuka, Kanagawa Dental University Hospital, Yokosuka, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juri Saruta
1Department of Environmental Pathology, Graduate School of Dentistry, Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Ino
5Department of Minimal Intervention Prosthodontics, Graduate School of Dentistry, Kanagawa Dental University, Yokohama, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Sakurai
6Department of Maxillofacial Radiology, Graduate School of Dentistry, Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Abundant secretory IgA (sIgA) in mucus, breast milk, and saliva provides immunity that prevents infection of mucosal surfaces. sIgA in pre-pandemic breast milk samples have been reported to cross-react with SARS-CoV-2, but whether it also occurs in saliva and, if so, whether it cross-reacts with SARS-CoV-2, has remained unknown. We aimed to clarify whether sIgA in saliva cross-reacts with SARS-CoV-2 spike 1 subunit in individuals who have not been infected with this virus. The study included 137 (male, n = 101; female, n = 36; mean age, 38.7 [24–65] years) of dentists and doctors in the Kanagawa Dental University Hospital. Saliva and blood samples were analyzed by PCR and immunochromatography for IgG and IgM, respectively. We then identified patients with saliva samples that were confirmed as PCR- and IgM-negative for COVID-19. Proportions of SARS-CoV-2 cross-reactive IgA-positive individuals were determined by enzyme-linked immunosorbent assay using a biotin-labeled spike S1-mFc recombinant protein covering the receptor-binding domain of SARS-CoV-2. The proportion of SARS-CoV-2 cross-reactive IgA-positive individuals was 46.7%, and this correlated negatively with age (r = −0.218, p = 0.01). The proportion of IgA-positive individuals ≥ 50 y was significantly lower than that of patients aged ≤ 49 y (p = 0.008). sIgA was purified from the saliva of all patients, and the salivary sIgA was found to suppress the binding of SARS-CoV-2 spike protein to the ACE-2 receptor. We found SARS-CoV-2 cross-reactive sIgA in the saliva of some participants who had never been infected with the virus, suggesting that sIgA helps prevent SARS-CoV-2 infection.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

The Japanese clinical trial registration system UMIN-CTR is a registration site that meets the ICMJE standards, and this study is registered in the UMIN-CTR (R000046461).

Clinical Protocols

https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view_his.cgi

Funding Statement

This research is funded by Kanagawa Dental University and is not received from other external institutions.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was conducted under the approval of the Kanagawa Dental University Research Ethics Review Board (Approval number: #690). This study was registered in the Japanese clinical trial UMIN-CTR (Approval number: #R000046461) registry, which meets ICMJE standards.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The P-value in the abstract has been revised to 0.008 to match the text. We also added one author. There is no change in the main text.

Data Availability

Access to the underlying data is not ready.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Detection of cross-reactive IgA against SARS-CoV-2 spike 1 subunit in saliva
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Detection of cross-reactive IgA against SARS-CoV-2 spike 1 subunit in saliva
Keiichi Tsukinoki, Tatsuo Yamamoto, Keisuke Handa, Mariko Iwamiya, Juri Saruta, Satoshi Ino, Takashi Sakurai
medRxiv 2021.03.29.21253174; doi: https://doi.org/10.1101/2021.03.29.21253174
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Detection of cross-reactive IgA against SARS-CoV-2 spike 1 subunit in saliva
Keiichi Tsukinoki, Tatsuo Yamamoto, Keisuke Handa, Mariko Iwamiya, Juri Saruta, Satoshi Ino, Takashi Sakurai
medRxiv 2021.03.29.21253174; doi: https://doi.org/10.1101/2021.03.29.21253174

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Dentistry and Oral Medicine
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (194)
  • Anesthesia (54)
  • Cardiovascular Medicine (488)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5661)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (856)
  • Geriatric Medicine (88)
  • Health Economics (229)
  • Health Informatics (759)
  • Health Policy (388)
  • Health Systems and Quality Improvement (250)
  • Hematology (105)
  • HIV/AIDS (181)
  • Infectious Diseases (except HIV/AIDS) (6455)
  • Intensive Care and Critical Care Medicine (388)
  • Medical Education (116)
  • Medical Ethics (28)
  • Nephrology (90)
  • Neurology (845)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (161)
  • Occupational and Environmental Health (258)
  • Oncology (514)
  • Ophthalmology (162)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (47)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (248)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (113)
  • Psychiatry and Clinical Psychology (959)
  • Public and Global Health (2222)
  • Radiology and Imaging (375)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (311)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)